# Label-free estimation of regulatory T cell activation markers using Raman spectroscopy with machine learning

**Authors:** Aria Azari-Pour, Ali Chamkalani, Shreyas Rangan, Katherine N. MacDonald, Miles Huynh, Megan K. Levings, H. Georg Schulze, James M. Piret, Bhushan Gopaluni

PMC · DOI: 10.1038/s41598-025-16002-8 · Scientific Reports · 2025-11-04

## TL;DR

This paper introduces a non-invasive method using Raman spectroscopy and machine learning to estimate regulatory T cell activation without the need for expensive and invasive lab tests.

## Contribution

A novel label-free method for monitoring regulatory T cell activation using Raman spectroscopy and machine learning is developed and validated.

## Key findings

- An L1-regularized least-squares model accurately estimated activation markers from Raman spectroscopy data.
- The model was validated on external donors, showing robust performance in predicting biomarker values.
- The method is suitable for integration into cell manufacturing devices for real-time monitoring.

## Abstract

Regulatory T cells are a class of T lymphocytes which respond to activation signals by expanding their cell numbers, and whose culturing and expansion are of significant clinical interest. Cellular activation states are used to inform process control decisions such as restimulation and can be probed with experimental measurements of cell surface markers. However, these measurements are expensive, time-consuming, and invasive, and an urgent need exists for devising a non-invasive method for activation state monitoring that could be deployed on-line. Raman spectroscopy is a label-free and information-rich optical method that, when coupled to data analytical methods, can ameliorate these experimental issues. In this work, we quantitatively estimated experimental measurements of regulatory T cell activation markers with high accuracy. We simulated a clinical manufacturing setting by building an \documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${L}_{1}$$\end{document}-regularized least-squares model with spectroscopic data from six regulatory T cell donors. Then, we validated the constructed model by accurately estimating different experimental measurements of biomarker values from two external donors, unseen by the model. We have devised a robust program to effectively estimate the activation state of regulatory T cells. We anticipate our method to be used with on-line Raman probes integrated into cell manufacturing devices for label-free monitoring of these processes.

The online version contains supplementary material available at 10.1038/s41598-025-16002-8.

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, LAP (Laryngeal adductor paralysis) [NCBI Gene 7939], FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}, LRRC32 (leucine rich repeat containing 32) [NCBI Gene 2615] {aka CPPRDD, D11S833E, GARP}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}
- **Diseases:** graft-versus-host disease (MESH:D006086), autoimmune disorders (MESH:D001327), cancer (MESH:D009369)
- **Chemicals:** penicillin (MESH:D010406), streptomycin (MESH:D013307), cholesterol (MESH:D002784), rapamycin (MESH:D020123), phosphatidylinositol (MESH:D010716), phenylalanine (MESH:D010649), phosphate buffered saline (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12586467/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12586467/full.md

---
Source: https://tomesphere.com/paper/PMC12586467